Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension

BACKGROUND: Published randomized controlled trials are underpowered for binary clinical end points to assess the safety and efficacy of renin‐angiotensin system inhibitors (RASi) in adults with COVID‐19. We therefore performed a meta‐analysis to assess the safety and efficacy of RASi in adults with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gnanenthiran, Sonali R., Borghi, Claudio, Burger, Dylan, Caramelli, Bruno, Charchar, Fadi, Chirinos, Julio A., Cohen, Jordana B., Cremer, Antoine, Di Tanna, Gian Luca, Duvignaud, Alexandre, Freilich, Daniel, Gommans, D. H. Frank, Gracia‐Ramos, Abraham E., Murray, Thomas A., Pelorosso, Facundo, Poulter, Neil R., Puskarich, Michael A., Rizas, Konstantinos D., Rothlin, Rodolfo, Schlaich, Markus P., Schreinlecher, Michael, Steckelings, Ulrike Muscha, Sharma, Abhinav, Stergiou, George S., Tignanelli, Christopher J., Tomaszewski, Maciej, Unger, Thomas, van Kimmenade, Roland R. J., Wainford, Richard D., Williams, Bryan, Rodgers, Anthony, Schutte, Aletta E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496439/
https://www.ncbi.nlm.nih.gov/pubmed/36000426
http://dx.doi.org/10.1161/JAHA.122.026143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496439/
https://www.ncbi.nlm.nih.gov/pubmed/36000426
http://dx.doi.org/10.1161/JAHA.122.026143

Ejemplares similares